Retatrutide 10mg

Description

Retatrutide is a peptide acting as a triple receptor agonist for GLP-1 receptors (GLP-1R), GIP receptors (GIPR), and glucagon receptors (GCGR). It enhances insulin secretion by activating GLP-1R, inhibits glucagon release, delays gastric emptying, and increases satiety; activates GIPR to enhance insulin sensitivity and regulate lipid metabolism; activates GCGR to promote energy expenditure, inhibit hepatic gluconeogenesis, and reduce hepatic fat deposition. This multi-target synergistic action makes it superior to traditional single-target GLP-1 drugs in lowering blood glucose, reducing body weight, and improving hepatic fat deposition.

The peptide will be provided as lyophilized powder to ensure maximum stability.